Montana Cancer Consortium

Analysis

Montana Cancer Consortium is a registered charity in United States, based in Billings, MT. It received its IRS tax-exemption ruling in January 1996, 30 years ago. Its declared purposes cover diseases, disorders and medical disciplines, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending May 2023, Montana Cancer Consortium reported income of $607k and spending of $858k, spending 141% of what it took in. Across the 5 years on record, from May 2019 to May 2023, income fell from $962k to $607k (-37%), an average of -11% a year. The sharpest change came in the year to May 2023, when income dropped by 32%. Over the whole period it spent 102% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Montana Cancer Consortium sits at the 58th percentile: it is larger than about 58% of them. Against every charity in United States with reported income it ranks in the 73rd percentile, and in the 74th percentile within MT. Charities of a similar size with the same main cause include 230 House ($606k), Foundation for Heart Failure Research Inc ($607k) and Bella Bowman Foundation Inc ($606k).

On its Form 990 for the period ending May 2023, revenue came from contributions and grants 100% of the total. Compensation of current officers, directors and key employees was $122k (14% of expenses). Other salaries and wages came to $152k. At year end it held assets of $361k against liabilities of $4,931, net assets of $357k. It reported 7 employees.